The Interdisciplinary Scientific Committee (ISC) is establishing a Task Force on Clinical Research Networks for Rare Diseases aiming to map and analyse the existing ecosystem of national/supranational clinical research networks, […]
Read MoreWe are pleased to announce the election of Dr Durhane Wong Rieger, President & CEO of the Canadian Organization for Rare Disorders (CORD), as the Chair of the Patient Advocacy […]
Read MoreThe Diagnostic Scientific Committee (DSC) is establishing a Task Force on to address barriers to the diagnosis of rare diseases for Indigenous peoples, so as to help address critical areas that will […]
Read More“We call for a global moratorium on all clinical uses of human germline editing — that is, changing heritable DNA (in sperm, eggs or embryos) to make genetically modified children”. […]
Read MoreThe International Rare Diseases Research Consortium support Rare Disease Day 2019! The recent elected Chair and Vice Chair of IRDiRC, Dr Lucia Monaco and Dr David Pearce, and the accompanying […]
Read MoreDimply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dumy text ever since the 1500s, when an unknown printer took a galley of […]
Read MoreDimply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dumy text ever since the 1500s, when an unknown printer took a galley of […]
Read MoreDimply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dumy text ever since the 1500s, when an unknown printer took a galley of […]
Read MoreDimply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dumy text ever since the 1500s, when an unknown printer took a galley of […]
Read MoreDimply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dumy text ever since the 1500s, when an unknown printer took a galley of […]
Read More